Laboratorios Richmond SACIF Capital Reinvestment Ratio

Latest as of June 2025: 9.90x

Laboratorios Richmond SACIF capital reinvestment ratio. Laboratorios Richmond SACIF (RICH) has a Capital Reinvestment Ratio of 9.90x as of June 2025, meaning it reinvests 10% of its operating cash flow (AR$760.81 Million) in capital expenditures (AR$7.53 Billion). Check Laboratorios Richmond SACIF cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

9.90x
Capex / Operating Cash Flow

Operating Cash Flow

AR$760.81 Million
ARS

Capital Expenditures

AR$7.53 Billion
ARS

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of Laboratorios Richmond SACIF (2006–2024)

Capital reinvestment ratio of Laboratorios Richmond SACIF from 2006 to 2024. This chart tracks Laboratorios Richmond SACIF's Capital Reinvestment Ratio across 9 annual periods. Also explore Laboratorios Richmond SACIF (RICH) equity growth momentum to track the company's year-over-year net asset growth rate.

Laboratorios Richmond SACIF Capital Reinvestment Ratio by Year (2006–2024)

Laboratorios Richmond SACIF capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see RICH cash flow conversion.

Year Reinvestment Ratio Operating CF (ARS) Capital Expenditures YoY Change
2024 1.57x AR$5.62 Billion AR$8.81 Billion ▲ +10.4%
2021 1.42x AR$7.27 Billion AR$10.32 Billion ▼ -54.7%
2019 3.13x AR$121.02 Million AR$378.66 Million ▼ -54.4%
2017 6.86x AR$11.18 Million AR$76.68 Million ▲ +157.3%
2011 2.67x AR$3.51 Million AR$9.37 Million ▲ +39.2%
2010 1.92x AR$8.30 Million AR$15.90 Million ▲ +52.3%
2009 1.26x AR$1.25 Million AR$1.58 Million ▲ +14.3%
2007 1.10x AR$6.73 Million AR$7.42 Million ▲ +16.1%
2006 0.95x AR$12.87 Million AR$12.20 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow